All you had to do was post your opinion, in one post, then if you wanted offer information. You wouldn't have been treated with suspicion if you did that. But 200 posts in less that 2 weeks with the same information? Not even the positive long-standing members would do that because their respect would have been lost. You do not post this many times on a BB with the same info and think people will just take it as gospel, because that sounds to me like what you're trying to achieve. Sorry but it won't just be me. The majority of the board will think the same. No one with sense will ever buy into a share based on posts on a BB no matter how many times in 10 minutes you post!
When have I ever said the deal is no good? At the time it was announced I said I thought is was a great deal as it derisks the financial side for SAR. If HMU testing fails, SAR don't have to waste any money and if it works, they will benefit from the data. You have mistaken this as derisking the clinical side of things. Which is totally seperate. It still might fail but the approach in the pharma world is if you kiss enough frogs, you might find a prince. They still end up kissing a lot of frogs as most phase 1 trials fail. Do you agree?
you keep up the positive. I will keep up the balanced. 200 plus posts of positivity doesn't change anything. There are risks despite you claiming that failure is not an option. And how can you say I'm being negative by alerting you to the "inhibited tumour growth completely" phrase?
"I wont keep on but news is due" - Then stop banging on about it then!
"I have no doubt that the Company will be dishing out meat on the bone and then I may be able to release my own technical update." - It is clear now that you are just blatantly, in bog standard vanilla style, ramping!
You've posted around 200 posts on this BB in less than 2 weeks. Now I'm all for support but it really is getting silly now.
...trying the same thing over and over expecting a different result.
fork. I have tried to get you to be a little more balanced. Failed and given up.
You want data? There is loads of it contained in the Aurora FLT3 patent. If you remember I provided you with a link the other day but you haven't commented on this once. I also told you where to look in the patent to find the most exciting 4 words (section 4, near the bottom)
These words are "inhibited tumour growth completely".
Can you please add this onto your list of often quoted phrases? I like being invested in a drug discovery company who have made this claim. It shows potential. I also like hearing it. Over and over again so feel free to repeat it as many times as you see fit.
You may want to caveat it by saying it was performed on mice and there is no guarantee that the results will be successfully replicated in people. But I will leave that part up to you.
It seems like you have pulled the SP up single handed with your 200+ posts over the last week and a half. What specifically are we looking for in the update to maintain the gain? Previously we were looking at H2 for the submission towards trials ....what has sped this up?
If I knew everything the market makers were doing, knew everything about the partners/collaberators we have entered into, knew there was lots of undeniably good news coming imminently and hadn't even started to tell everyone about the technical stuff (wild guess here, it's quite bullish) then I'd be as wildly positive about everything.
Mind you, I 'd be beg borrowing and stealing whatever I could rather than sharing it 20+ times a day on an anonymous board
Datafeed and UK data supplied by NETbuilder and Interactive Data.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.